BIOXCEL THERAPEUTICS INC (BTAI) Stock Income Statement
NASDAQ:BTAI - US09075P2048 - Common Stock
4.1 USD
+0.14 (+3.54%)
4.0797 USD
-0.02 (-0.5%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 868.00K | 2.27M | 1.38M | 380.00K | 0.00 | |||
| Cost Of Goods | 2.12M | 2.14M | 1.26M | 20.00K | N/A | |||
| Gross Profit | -1.25M | 123.00K | 120.00K | 360.00K | N/A | |||
| Operating Expenses | 48.90M | 64.93M | 167.74M | 160.00M | 106.94M | |||
| Research and Development | 25.81M | 30.43M | 84.33M | 91.24M | 52.71M | |||
| Selling, General, and Administrative Expenses | 23.09M | 34.49M | 83.41M | 68.76M | 54.23M | |||
| Operating Income | -50.15M | -64.80M | -167.62M | -159.65M | -106.94M | |||
| Interest Income/Expense | -14.54M | -12.53M | -7.67M | -5.69M | 0.00 | |||
| Other Income/Expense | 15.33M | 20.17M | 394.00K | -430.00K | N/A | |||
| Non Recurring Items | N/A | -2.44M | -4.16M | N/A | N/A | |||
| Income Before Taxes | -50.95M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -50.95M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| EBITDA | -49.85M | -64.50M | -167.30M | -159.32M | -106.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.38 | -23.51 | -98.35 | -94.66 | -64.87 | |||
| Non GAAP EPS | -12.64 | -25.97 | -98.40 | -94.59 | -65.28 | |||
| Statistics | ||||||||
| Gross Profit Margin | -144.59% | 5.43% | 8.70% | 94.74% | N/A | |||
| Profit Margin | -5869.82% | -2630.14% | -12974.86% | -43621.05% | N/A | |||
| Operating Profit Margin | -5777.88% | -2859.84% | -12146.30% | -42013.16% | N/A | |||
All data in USD